
Clario CTMS
Clinical trial management systems
Life sciences software
Clinical research software
- Features
- Ease of use
- Ease of management
- Quality of support
- Affordability
- Market presence
Take the quiz to check if Clario CTMS and its alternatives fit your requirements.
<$100,000 one-time
Small
Medium
Large
-
What is Clario CTMS
Clario CTMS is a clinical trial management system used to plan, track, and manage operational activities across clinical studies. It supports sponsors, CROs, and clinical operations teams with study, site, and subject-level tracking, including milestones, monitoring activities, and document-related workflows. The product is positioned within Clario’s broader eClinical portfolio, which can be relevant for organizations that want CTMS aligned with other clinical technology services from the same vendor.
Designed for clinical operations tracking
The system focuses on core CTMS functions such as study planning, site management, subject tracking, and operational milestone oversight. This supports day-to-day clinical operations workflows that require consistent status visibility across many sites. It aligns with common CTMS expectations in the category, including monitoring and activity tracking needed for trial execution.
Portfolio alignment with eClinical services
Clario operates across multiple clinical technology and service areas, and CTMS can be used in environments where teams prefer a consolidated vendor relationship. This can reduce vendor management overhead when CTMS is deployed alongside other clinical systems and services. For organizations standardizing on a single provider for multiple trial functions, this alignment can be a practical advantage.
Enterprise vendor support model
As part of a large clinical technology provider, Clario CTMS is typically delivered with enterprise-grade implementation and support options. This can be important for regulated environments that require validated processes, controlled change management, and formal support channels. Larger organizations may benefit from structured delivery and governance compared with lighter-weight tools.
Less transparent public product detail
Compared with some CTMS products that publish extensive self-service documentation and detailed feature matrices, publicly available information on Clario CTMS can be limited. This can make early-stage evaluation, requirements mapping, and stakeholder demos harder without direct vendor engagement. Buyers may need more time for discovery and validation during procurement.
Potential dependency on vendor ecosystem
Organizations that adopt CTMS as part of a broader vendor portfolio may become more dependent on that vendor’s roadmap, services, and integration approach. If a buyer prefers a best-of-breed stack, they may need to confirm integration depth, data portability, and interoperability with existing eClinical and enterprise systems. This can increase due diligence effort for IT and clinical systems teams.
Implementation effort for complex studies
CTMS deployments often require configuration for study templates, roles, workflows, and reporting to match an organization’s operating model. For complex global trials, this can translate into longer implementation timelines and change management needs. Teams should plan for process standardization, training, and ongoing administration to sustain data quality.
Plan & Pricing
Pricing model: Use-based / Pay-as-you-go (pricing based on number of active studies and users). Free tier/trial: No permanent free tier or time-limited free trial stated on the official site. Example costs: CTMS Starter Package – deployed in 2–3 weeks for < $100,000 (one-time starter package). Pricing notes: Clario states pricing is use-based and may be based on number of active studies and users; no public per-user or per-month rates are published on the vendor site. Contact sales for custom quotes.
Seller details
Clario
Philadelphia, PA, USA
1972
Private
https://www.clario.com/
https://x.com/ClarioGlobal
https://www.linkedin.com/company/clario/